Association of matrix acid and alkaline phosphatases with mineralization of cartilage and endochondral bone.
The activities of acid and alkaline phosphatases were localized by enzyme histochemistry in the chondroepiphyses of 5 week old rabbits. Using paraformaldehyde-lysine-periodate as fixative, the activity of acid phosphatase was particularly well preserved and could be demonstrated not only in osteoclasts, but also in chondrocytes as well as in the cartilage and early endochondral matrices. The acid phosphatase in the chondrocytes and the matrix was tartrate-resistant, but inhibited by 2 mM sodium fluoride, whereas for osteoclasts 50-100 mM sodium fluoride were required for inhibition. Simultaneous localisation of both acid and alkaline phosphatase activities was possible in tissue that had been fixed in 85% ethanol and processed immediately. In the growth plates of the secondary ossification centre and the physis, there was a sequential localisation of the two phosphatases associated with chondrocyte maturation. The matrix surrounding immature epiphyseal chondrocytes or resting/proliferating growth plate chondrocytes contained weak acid phosphatase activity. Maturing chondrocytes were positive for alkaline phosphatase which spread to the matrix in the pre-mineralizing zone, in a pattern that was consistent with the known location of matrix vesicles. The region of strong alkaline phosphatase activity was the precise region where acid phosphatase activity was reduced. With the onset of cartilage calcification, alkaline phosphatase activity disappeared, but strong acid phosphatase activity was found in close association with the early mineral deposition. Acid phosphatase activity was also present in the matrix of the endochondral bone, but was only found in early spicules which had recently mineralised. The results suggest that alkaline phosphatase activity is required in preparation of mineralization, whereas acid phosphatase activity might have a contributory role during the early progression of mineral formation.
Roach
H I
HI
University Orthopaedics, University of Southampton, General Hospital, UK.
D000135:Acid Phosphatase / Q000378:metabolism*; D000469:Alkaline Phosphatase / Q000378:metabolism*; D000818:Animals; D001846:Bone Development; D001857:Bone Matrix / Q000201:enzymology*; D001842:Bone and Bones / Q000201:enzymology / Q000502:physiology*; D002113:Calcification, Physiologic; D002356:Cartilage / Q000201:enzymology / Q000254:growth & development / Q000502:physiology*; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D005404:Fixatives / Q000494:pharmacology; D005557:Formaldehyde / Q000494:pharmacology; D006132:Growth Plate / Q000187:drug effects / Q000201:enzymology; D007527:Isoenzymes / Q000378:metabolism; D008239:Lysine / Q000494:pharmacology; D010504:Periodic Acid / Q000494:pharmacology; D011108:Polymers / Q000494:pharmacology; D011817:Rabbits; D000071681:Tartrate-Resistant Acid Phosphatase; D013644:Tartrates / Q000494:pharmacology; D016707:Tissue Fixation
D005404:Fixatives; D007527:Isoenzymes; D011108:Polymers; D013644:Tartrates; D010504:Periodic Acid; D005557:Formaldehyde; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase; D008239:Lysine; C029768:tartaric acid; C003043:paraform